
News
from the fight to #SaveIndiePharmacy
New York Times’ The Middlemen series

Eagan’s Prime Therapeutics hit with $10.3M judgment in price-fixing case
Safety net provider alleged pharmacy benefit manager collaborated with a rival to set low payment rates to pharmacies.

PBM Prime Therapeutics to Pay $10 Million Antitrust Case Over Price-Fixing Scheme with Express Scripts, Inc.
In a recent antitrust arbitration ruling, Prime Therapeutics, a pharmacy benefit manager (PBM) owned by 19 Blue Cross and Blue Shield Plans, was found guilty of engaging in horizontal price-fixing in collaboration with Express Scripts, Inc. (ESI), a competitor owned by Cigna.
Drugmakers including Purdue Pharma paid pharmacy benefit managers not to restrict painkiller prescriptions, a New York Times investigation found.